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Introduction
============

Globally, malaria is a common cause of recurring fevers and is recognized to have high endemicity in sub-Saharan Africa and parts of Asia. However, malaria is also common outside of Africa and presents similarly but has distinct clinical differences. Blood smears with Giemsa stain are the gold standard for diagnosis \[[@REF1]\]. However, some species of Plasmodium are less detectable in peripheral blood, and negative blood smears do not rule out the diagnosis \[[@REF2],[@REF3]\].

Case presentation
=================

A 56-year-old man presented to the emergency department (ED) after experiencing a fever to 101°F (38.3°C) at home. His past medical history included intermittent febrile episodes over the past seven years and hypertension. His only medication was hydrochlorothiazide.

He experienced recurrent unprovoked febrile episodes (occurring every two to three months) for the past seven years. These episodes were acute in onset, without preference for day or night, and followed a stereotypic pattern. They began with chills/rigors followed by high-grade fever, severe day/nighttime diaphoresis, nausea, and sometimes palpitations. Spontaneous resolution typically occurred within 24-48 hours and left him feeling severely fatigued the following day. The highest fever he recorded during an episode was 104.1°F (40.1°C). He denied vomiting, diarrhea, abdominal pain, dysuria, arthralgias, myalgias, or unexpected weight loss in association with these episodes. Between episodes, he felt completely asymptomatic.

Five years prior to presentation, the patient resided in China for seven years. He also endorsed travel history to Taiwan, Malaysia, Thailand, Philippines, Korea, Japan, Costa Rica, and the Dominican Republic. He reports taking appropriate preventive measures against mosquitoes such as barriers and chemical prophylaxis while traveling. His first febrile episode occurred in Taiwan within the seven-year period when he was residing in China. Initially, after returning from China, he experienced dyspnea and chest pain with a negative cardiac and pulmonary workup.

He did not endorse any illicit drug use, tobacco use, and seldomly consumed alcohol. He was up to date with his preventive health screening exams. Family history was significant for rheumatoid arthritis in his sister. There was no other history of autoimmune disease or familial fever syndromes in his family.

The patient was admitted for systemic inflammatory response syndrome (SIRS) and for a diagnostic assessment for fever of unknown origin. Diagnostic labs and imaging are summarized in Table [1](#TAB1){ref-type="table"} and Table [2](#TAB2){ref-type="table"}, respectively. Many of these were repeated during periods of fever without a significant difference in results. An extensive rheumatologic and infectious workup was negative and oncology was consulted with low suspicion for malignancy. The infectious disease service was consulted and reported concern for malaria (particularly *Plasmodium vivax* (*P. vivax*) and *Plasmodium ovale* (*P. ovale*)) and brucellosis due to his travel history, although there lacked typical periodicity. They noted that splenomegaly, anemia, thrombocytopenia, and mild transaminitis seemed consistent with malaria. A malaria expert was consulted at the Centers for Disease Control and recommended empiric treatment for malaria based on the patient's history and clinical findings. Following a negative glucose-6-phosphate dehydrogenase (G6PD) deficiency screen, the patient was started on empiric treatment with oral atovaquone/proguanil 1000/400 mg for three days and primaquine 30 mg daily for 14 days.

###### Blood tests

Rheumatologic workup was negative for anti-Smith antibody, anti-SS-A antibody, anti-SS-B antibody, antinuclear antibodies (ANA), anti-dsDNA antibody, and rheumatoid factor. Infectious workup was negative for anaplasmosis, babesiosis, erlichiosis, malaria, Lyme, syphilis, tuberculosis, hepatitis B, hepatitis C, HIV, cytomegalovirus (CMV), and Epstein-Barr virus (EBV).

  --------------------------------------------------------- ----------------------
  Lab                                                       Measured value
  High sensitivity troponin                                 \< 6 (N)
  D-dimer                                                   434 (H)
  International normalized ratio (INR)                      1.23 (N)
  Prothrombin time (PT)                                     13.6 (H)
  Partial thromboplastin time (PTT)                         24 (N)
  Urinalysis                                                Unremarkable
  Urine drug screen                                         Negative
  Urine culture                                             Negative
  White blood cell                                          7.6 (N)
  Neutrophil                                                91.40%
  Lymphocytes                                               5.00%
  Monocytes                                                 2.90%
  Eosinophils                                               0.30%
  Basophils                                                 0.10%
  Red blood cell                                            4.13 (L)
  Hemoglobin                                                13.3 (L)
  Platelet                                                  115 (L)
  Blood cultures                                            Negative
  Blood smear                                               Unremarkable
  Lactate                                                   2.6 (H)
  C-reactive protein                                        0.30 (N)
  Erythrocyte sedimentation rate                            3 (N)
  Thyroid stimulating hormone                               1.31 (N)
  Lactate dehydrogenase                                     162 (H)
  Haptoglobin                                               75 (N)
  Total bilirubin                                           1.3 (H)
  Aspartate aminotransferase                                45 (H)
  Alanine aminotransferase                                  76 (H)
  Alkaline phosphatase                                      56 (N)
  Iron                                                      28 (L)
  Total iron binding capacity                               247 (L)
  Iron saturation                                           11% (L)
  Ferritin                                                  839 (H)
  Anti Smith Antibody                                       8
  Anti SS-A Antibody                                        19
  Anti SS-B Antibody                                        1
  ANA screen                                                Negative
  Anti dsDNA Antibody                                       5
  Rheumatoid Factors                                        11
  A. phagocytoph. IgG                                       \<1:64
  A. phagocytoph. IgM                                       \<1:20
  Ehrlichia chaffeensis IgG                                 \<1:64
  Malaria Antigen Screen                                    Presumptive Negative
  Lyme Ab screen                                            1.75 (equivocal)
  Lyme Disease Ab (IgM)                                     Negative
  Lyme Disease Ab (IgG)                                     Negative
  Syphilis Antibody                                         Negative
  Quantiferon Result                                        Negative
  Tuberculosis Antigen                                      ≤ 0.000
  Hep B Surf Antigen                                        Non-reactive
  Hep C Antibody                                            Non-reactive
  HIV Ab/Ag Result                                          Non-reactive
  Cytomegalovirus polymerase chain reaction (PCR), Plasma   \<100 IU/mL
  Ebstein-Barr virus quantitative PCR, Plasma               Non detected
  Mono Screen                                               Non-reactive
  Babesia microti DNA reverse transcriptase-PCR             Not detected
  Babesia microti DNA PCR                                   Not detected
  --------------------------------------------------------- ----------------------

###### Imaging findings

  ----------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Imaging                                                           Findings
  Chest X-ray                                                       Unremarkable
  Computed tomography (CT) angiography of pulmonary embolism (PE)   Negative for PE, mild interlobular interstitial thickening possibly representing pulmonary edema. Cardiac morphology and pericardium were unremarkable.
  CT abdomen pelvis                                                 Mild splenomegaly measuring 16 x 12 cm, trace amounts of free fluid in the lower pelvis of uncertain etiology, and an enlarged lymph node near the liver.
  ----------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------

Three weeks following discharge, the patient was seen for outpatient follow-up. The anemia was resolving with a hemoglobin of 13.3 g/dL; thrombocytopenia fully resolved with a platelet count of 169 B/L. Mild transaminitis persisted (aspartate aminotransferase (AST) 42 IU/L, alanine aminotransferase (ALT) 64 IU/L), total bilirubin had returned to normal (0.7 mg/dL), and alkaline phosphatase (ALP) remained normal at 58 IU/L. Though the improvement in labs may have simply reflected the resolution of SIRS, the patient reported no additional fevers during a telehealth follow-up one year later.

Discussion
==========

The most common causes of recurrent febrile episodes include infectious, rheumatologic, and oncologic etiologies. Oncology did not suspect malignancy as the febrile episodes were too far inconsistent, complete blood cell count (CBC) and smear were normal, and the patient was up to date on cancer screening without a high-risk family history. Rheumatology had low suspicion for an autoinflammatory disorder as the patient had a lack of arthralgias and rash, was completely asymptomatic between episodes, and workup for common autoimmune disorders were negative. Finally, workup for common infectious etiologies including viral, bacterial, and parasitic were negative. Despite this, based on the patient\'s travel history and clinical presentation, malaria was still highly suspected \[[@REF4]\].

There are five Plasmodium species known to infect humans: falciparum, malariae, ovale, vivax, and knowlesi \[[@REF1]\]. *Plasmodium falciparum (P. falciparum*) is the most common, accounting for 99% of known malaria cases, and generally is geographically-limited to sub-Saharan Africa \[[@REF2],[@REF5]\]. *P. vivax* is the most common species outside of Africa and accounts for 50% of non-African cases in the Americas, Eastern Mediterranean region, and Asia \[[@REF2],[@REF5]\]. In Asia, the burden of *P. vivax* has been reported to be as high as 80% of the total global burden \[[@REF4]\]. Other species in this region include *Plasmodium knowlesi*,*P. ovale*,*and Plasmodium malariae* \[[@REF2],[@REF6]\].

Due to the infrequency of febrile episodes in this case, a Plasmodium species capable of producing hypnozoites seems most likely. Only *P. vivax* is confirmed to have a latent state in the liver (hypnozoites) with the ability to remain dormant for up to two years after primary infection \[[@REF3]\]. *P. ovale* is suspected to have a hypnozoite stage as well, however, the evidence for this is limited and controversial \[[@REF6]\]. Both *P. vivax*and *P. ovale* have reported relapse periods consistent with our patient's presentation, however, *P. ovale* less commonly produces clinical malaria and is more common in Africa than Asia \[[@REF6],[@REF7]\]. *P. vivax* is not commonly seen in Africa due to the lack of the Duffy antigen on erythrocytes in the region \[[@REF2]\].

The classic episode of *P. vivax* infection begins with a prodrome of headache, anorexia, malaise, myalgias, and gastrointestinal symptoms for one or more days followed by a remitting fever \[[@REF2]\]. Subsequent paroxysmal episodes occur in response to the rupturing of schizont-infected red blood cells (RBCs) \[[@REF2]\]. These episodes begin with a stage of chills and rigors that last for approximately one hour, followed by fevers peaking 1-3 hours after rigors subside, and defervescence accompanied by diaphoresis and fatigue \[[@REF2]\]. In comparison to *P. falciparum*, *P. vivax* induces an inflammatory response at a significantly lower parasite load \[[@REF2]\]. Additionally, *P. vivax* has a predilection for reticulocytes, ultimately infecting \< 2% of circulating erythrocytes while maintaining a greater capacity of causing severe anemia than *P. falciparum* \[[@REF2]\]. The frequency of relapse depends on the infecting geographic strain of *P. vivax* \[[@REF2]\]. Tropical strains relapse more frequently, from 1-6 months, and temperate strains relapse at intervals of eight months or greater \[[@REF2]\].

Clinical signs and abnormalities

D-dimer is often elevated during malarial infections \[[@REF8]\]. *P. falciparum* is well known to cause adherence of infected RBCs to the endothelium, causing damage and activation, and subsequently elevating D-dimer levels \[[@REF8]\]. *P. vivax* is reported to have the same effect albeit with a 10-fold lower capacity. D-dimer levels in-turn reflect these pathophysiological differences \[[@REF8]\].

In our case, our patient had a mild transaminitis and mild hyperbilirubinemia. Severe malarial infections can cause "malarial hepatopathy" which are defined by severe elevations of liver function tests \[[@REF9]\]. These serologic elevations are higher in *P. falciparum*than *P. vivax* infections, suggesting that the etiology is more likely related to falciparum-specific etiologies (e.g. increased RBC cytoadherence) and not the presence of hepatic hypnozoites in *P. vivax* \[[@REF9],[@REF10]\]. Our patient did not meet the criteria for malarial hepatopathy. We observed mild splenomegaly in our patient, a highly specific finding of malarial infection, and may simply reflect normal splenic filtration of abnormal RBCs, vascular congestion due to malaria, and organ-specific immune response against malaria \[[@REF10],[@REF11]\].

On CT, our patient was found to have mild pulmonary edema and free peritoneal fluid. These findings are rarely reported in non-severe malarial infections and consistent with the effects that malaria exerts on endothelium and microvascular function \[[@REF8],[@REF12]\].

Thrombocytopenia commonly occurs in malaria as well. The exact mechanism is not completely understood but centers around immunologic mechanisms damaging thrombocytes and causing excess platelet removal \[[@REF13]\]. Thrombocytopenia is reported to have high sensitivity (94%), high specificity (73%), and a high negative predictive value (97%) for malaria \[[@REF14]\].

Diagnostic studies

Analysis of thick smear blood samples under light microscopy has greater sensitivity for diagnosing *P. falciparum*than *P. vivax* due to *P. vivax* having a preference for infecting pre-circulating reticulocytes \[[@REF3],[@REF15]\]. Serologic testing for lactate dehydrogenase (LDH) and aldolase is useful but requires a moderately elevated parasitemia \[[@REF3]\]. Antigen-detecting rapid diagnostic tests (RDTs) are now one of the most prevalent diagnostic tools used worldwide reaching areas where microscopy and polymerase chain reaction (PCR) are limited \[[@REF16]\]. Overall, PCR testing tends to be the most sensitive as it is able to assess the presence of malaria, even with low parasite counts \[[@REF17]\]. We identified only one other report of malaria with negative PCR \[[@REF18]\]. In settings where laboratory testing is limited or high suspicion is not corroborated by diagnostic serologies (as in our case), other clinical findings have consistently been shown to support a diagnosis of malaria. Positive predictors include fever, non-pulsatile headache, chills and rigor, and periodicity to these symptoms \[[@REF19],[@REF20]\]. Negative predictors include conjunctival suffusion, rash, respiratory rate \>28, severe arthralgia/myalgia, throat congestion, fever \>40 C°, and continuous fever \[[@REF19],[@REF20]\]. A previous study reports that among travelers returning to the U.S, the most supportive clinical findings for malaria were splenomegaly, hepatomegaly, hyperbilirubinemia, and thrombocytopenia \[[@REF10]\]. From this case, additional predictors may include imaging findings of non-specific fluid shifts (pulmonary edema, peritoneal fluid) reflecting malaria-induced endothelial dysfunction and hepatic lymphadenopathy reflecting hepatic hypnozoite activity.

When the malaria species is unknown, the World Health Organization recommends treatment under the assumed diagnosis of uncomplicated malaria by *P. falciparum*. This means that artemisinin-based combination therapies should be primarily utilized, mainly for its ability to overcomes chloroquine-resistance. If the patient has G6PD, treatment should be centered around primaquine. Additional treatment with primaquine for 14 days in all transmission settings should be performed to prevent relapse \[[@REF1]\].

Conclusions
===========

Malaria is common and endemic to many countries outside of Africa (e.g. Asia), with *P. vivax* as the predominating, causative species. PCR is the best test when suspicious for *P. vivax*, however, it is not always diagnostic. Recurrence of febrile episodes maybe months to years apart. Clinical signs supportive of a malarial infection are fever, rigors, chills, hepato/splenomegaly, hyperbilirubinemia, and thrombocytopenia. Severe manifestations of malaria are life-threatening. G6PD should be tested for prior to empiric treatment. When the malarial organism is unknown, treatment is approached as if the patient has an uncomplicated *P. falciparum* infection.

The authors have declared that no competing interests exist.

Consent was obtained by all participants in this study. Jefferson - Office of Human Research issued approval N/A. OHR-34: Item 9: Case reports of one or two cases. (Three or more case reports in one series require IRB review). While one or two case reports do not require IRB review, they do require review by the Privacy Office.

Special thanks to Dr. Lily Ackermann and Dr. Sean Clark-Garvey for their clinical preceptorship and Jennifer Wilson for her thoughtful and detailed revisions. Publication made possible in part by support from the Thomas Jefferson University + Philadelphia University Open Access Fund.
